FindTrial
Sign In

Greater Occipital Nerve Block as a Treatment of Medication Overuse Headache (MOH-GON) Study

Greater Occipital Nerve Block For Treatment of Medication Overuse Headache: A Randomized double blind placebo controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097744
Enrollment
40
Registered
2025-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G444- Drug-induced headache, not elsewhere classified

Interventions

Intervention1: Greater Occipital Nerve Block: Greater Occipital Nerve Block with local anaesthetic drug (Lignocaine 2%) for medication overuse headache. Control Intervention1: No intervention: No inte

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years Patients giving informed consent Patients fulfilling criteria for medication overuse headache

Exclusion criteria

Exclusion criteria: Patients with secondary headache Known allergy to lignocaine Arnold chiari malformation or open skull defect Patients on Oral anticoagulants or bleeding disorder Pregnant women

Design outcomes

Secondary

MeasureTime frame
50% reduction in headache severity based on visual analogue scaleTimepoint: Week 4 and week 8 post intervention;Impact on functional disability based on headache impact test-6 (HIT-6) questionnaireTimepoint: Week 4 and week 8 post intervention—

Primary

MeasureTime frame
50% reduction in headache frequencyTimepoint: Week 4 and week 8 post intervention—

Countries

India

Contacts

Public ContactVimal K Paliwal

Sanjay Gandhi Postgraduate Institute of Medical Sciences

dr_vimalkpaliwal@rediffmail.com8004904631

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026